PAVmed Inc. (NASDAQ:PAVMZ) Short Interest Update

PAVmed Inc. (NASDAQ:PAVMZGet Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 5,200 shares, a drop of 66.0% from the March 31st total of 15,300 shares. Based on an average daily volume of 9,200 shares, the days-to-cover ratio is presently 0.6 days.

PAVmed Trading Down 33.0 %

Shares of NASDAQ PAVMZ traded down $0.01 during mid-day trading on Thursday, hitting $0.02. 35,055 shares of the stock traded hands, compared to its average volume of 11,478. PAVmed has a twelve month low of $0.00 and a twelve month high of $0.27. The firm has a 50 day simple moving average of $0.04 and a two-hundred day simple moving average of $0.08.

About PAVmed

(Get Free Report)

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.

Further Reading

Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.